Article
Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease.
Neurobiology of aging - 1 Mar 2009
Tan E K, Lee J, Chen C P, Wong M C, Zhao Y
Abstract excerpt
Alzheimer's disease (AD) pathology has been described in Parkinson's disease (PD) patients with leucine-rich repeat kinase-2 (LRRK2) mutations. A common LRRK2 Gly2385Arg variant has been widely shown to be associated with a twofold increased risk of PD in various Asian populations. In a case control study, the frequency of the heterozygous Gly2385Arg genotype was demonstrated in 4.3% of AD compared to 4.5% in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
